Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0151355 Pharmaceutical Formulation Containing Gelling Agent
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together...
2016/0151354 ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress...
2016/0151353 ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress...
2016/0151352 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS,...
The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxymorphone...
2016/0151351 NON-ABUSABLE PHARMACEUTICAL COMPOSITION COMPRISING OPIOIDS
There is provided pharmaceutical compositions for the treatment of pain comprising a pharmacologically-effective amount of an opioid analgesic, or a...
2016/0151350 PHARMACEUTICAL COMPOSITIONS WHICH INHIBIT FKBP52-MEDIATED REGULATION OF ANDROGEN RECEPTOR FUNCTION AND METHODS...
Pharmaceutical compositions that bind to a predicted FK506 Binding Protein 52 (FKBP52) interaction surface on the androgen receptor hormone binding domain,...
2016/0151349 PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING...
The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a...
2016/0151348 COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES
Methods for preventing or treating retroviral infection not HIV and/or for preventing, inhibiting or treating a disease caused by the retroviral infection...
2016/0151347 PHARMACEUTICAL COMPOUNDS
The present invention provides hydroxychloroquine or a pharmaceutically acceptable salt thereof for use in the prevention and/or treatment of systolic heart...
2016/0151346 N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARB- OXAMIDE, PREPARATION AND USES THEREOF
The subject invention provides a pharmaceutical composition containing laquinimod or a pharmaceutically acceptable salt thereof, and a compound of...
2016/0151345 N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARB- OXAMIDE, PREPARATION AND USES THEREOF
The subject invention provides a pharmaceutical composition containing laquinimod or a pharmaceutically acceptable salt thereof, and a compound of...
2016/0151344 COMPOUNDS FOR USE IN THE TREATMENT OF NEUROBLASTOMA, EWING'S SARCOMA OR RHABDOMYOSARCOMA
The present invention relates to a method of treating cancer selected from the group consisting of neuroblastoma, Ewing's Sarcoma, or rhabdomyosarcoma...
2016/0151343 NON-FLUSHING NIACIN ANALOGUES, AND METHODS OF USE THEREOF
One aspect of the present invention relates to substituted pyridines and pharmaceutically acceptable salts thereof that are active against a range of mammalian...
2016/0151342 COMPOUNDS AND METHODS TO TREAT ORGANOPHOSPHORUS POISONING
Organophosphate (OP) nerve agents and pesticides are potent inhibitors of acetylcholinesterase (AChE). Though oxime nucleophiles can reactivate an ...
2016/0151341 TREATMENT OF ENERGY UTILIZATION DISEASE
Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or...
2016/0151340 BOWEL CLEANSING COMPOSITION
A bowel cleansing composition includes as a first cleansing ingredient, a specific sugar alcohol such as xylitol, sorbitol, etc., as a second cleansing...
2016/0151339 Treatment for Chemotherapy-Induced Peripheral Neuropathy
The present invention provides methods and compositions for treating chemotherapy induced peripheral neuropathy. One embodiment of the present invention is...
2016/0151338 NUTRACEUTICAL COMPOSITION FOR THE TREATMENT OF EXCESS WEIGHT AND MODERATE HYPERCHOLESTEROLEMIA/DYSGLYCEMIA
A nutraceutical composition is provided for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia, comprising: Berberine, Monacolin K,...
2016/0151337 ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS
The invention relates to substituted bicyclic pyrroloheterocyclyl compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these...
2016/0151336 COMPOUNDS AND METHODS FOR REGULATING INTEGRINS
A method of treating inflammation, by administering an effective amount of a .beta.2 integrin agonist to a patient, and reducing inflammation. A method of...
2016/0151335 METHODS OF MODULATING CFTR ACTIVITY
The invention encompasses methods of modulating CFTR activity in a subject in need thereof comprising administering an effective amount of a compound of...
2016/0151334 SUBSTANCE HAVING TYROSINE KINASE INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREOF
Disclosed in the present disclosure are substances having tyrosine kinase inhibitory activity and a preparation method and use thereof, wherein the substances...
2016/0151333 METHODS AND COMPOSITIONS TO PREVENT OR TREAT BACTERIAL INFECTIONS
Certain embodiments are directed to methods and compositions for preventing or treating bacterial infections. In certain embodiments the compositions comprise...
2016/0151332 4-Methylpyrazole Formulations
Provided herein are 4-methylpyrazole (4-MP) formulations, stable under storage conditions of up to about 55.degree. C.
2016/0151331 METHODS OF USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOI- ...
Stereomerically pure (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione, substantially free of its (-) isomer, and...
2016/0151330 HEPATOCYTE-PROLIFERATING AGENT
The present invention relates to a hepatocyte-proliferating agent comprising pyroglutamic acid, aspartic acid, and glutamic acid as active ingredients, in...
2016/0151329 METHOD OF PRODUCING PROANTHOCYANIDIN OLIGOMER
The present invention relates to a composition containing as its main component proanthocyanidin oligomer to which a substance having a phloroglucinol ring...
2016/0151328 Terpene-Based Compositions, Processes Methodologies
The described invention included compositions comprising select terpenes, mapped from nature but improved with at least one of triacetin, dipropylene glycol,...
2016/0151327 Methods of Reducing Blood Lactate Concentration
The present invention is directed to methods for reducing blood lactate concentration during exercise, physical activity or athletic performance.
2016/0151326 Dronedarone for use in Leishmaniasis, Formulations and Associations for Use in Leishmaniasis
The invention relates to dronedarone or one of its pharmaceutically acceptable salts for the treatment of leishmaniasis, formulations and associations...
2016/0151325 NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF
In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of substantially water insoluble...
2016/0151324 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS
Improvements in or relating to Allium extracts. In particular, improvements in or relating to extending the therapeutic half-life or duration of Allium...
2016/0151323 METHODS FOR TREATING LEUKOPENIA AND THROMBOCYTOPENIA
The disclosure provides methods for treating, controlling or mitigating leukopenia (e.g. neutropenia) and/or thrombocytopenia, for example in the context of...
2016/0151322 METALLO-B-LACTAMASE INHIBITORS
A new metallo-.beta.-lactamase inhibitor which acts as a medicament for inhibiting the inactivation of .beta.-lactam antibiotics and recovering anti-bacterial...
2016/0151321 METHODS FOR THE TREATMENT OF SIALORRHEA
The present invention provides safe and effective methods for the treatment of sialorrhea (excessive drooling) by administering an effective amount of...
2016/0151320 USE OF DHA, EPA OR DHA-DERIVED EPA FOR TREATING A PATHOLOGY ASSOCIATED WITH CELLULAR OXIDATIVE DAMAGE
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing...
2016/0151319 SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
A self-emulsifying composition contains: 70 to 90% by weight in total of one or more compounds selected from the group consisting of .omega.3 polyunsaturated...
2016/0151318 USE OF NITRATED LIPIDS FOR TREATMENT OF LIPID DISORDERS AND OBESITY, AND LIPID- AND OBESITY-RELATED CONDITIONS
The present invention relates to methods of treating lipid disorders, lipid-related disorders or conditions, obesity and obesity-related disorders using...
2016/0151317 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or...
2016/0151316 METHOD OF TREATING TOURETTE'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS
The present invention is a method of treating Tourette's Disorder (TD) using GABA ergic drugs that elevate the amount of stored presynaptic GABA and do not...
2016/0151315 S ISOMERS OF ALPHA-METHYL-HYDROCINNAMIC ACID FOR THE TREATMENT OF BLOOD DISORDERS
The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood...
2016/0151314 Facially Amphiphilic Polymers and Oligomers and Uses Thereof
The present invention discloses methods of use of facially amphiphilic polymers and oligomers, including pharmaceutical uses of the polymers and oligomers as...
2016/0151313 TOPICAL COMPOSITION AND DELIVERY SYSTEM AND ITS USE
The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need...
2016/0151312 POLYAMINE TRANSPORT INHIBITORS AS NOVEL THERAPEUTICS
Novel polyamine transport inhibitors have been synthesized and demonstrated to block the uptake of native polyamines into human cancer cells. A combination...
2016/0151311 N,N'-DI-1 NAPHTHYLGUANIDINE HCL (NAGH) AND N,N'-DI-P-NITROPHENYLGUANIDINE HCL (NAD) TREATMENT FOR STROKE AT...
A method of treating stroke by administration of a novel sigma agonist is presented. Twenty-four hours after MCAO, systemic administration of several novel...
2016/0151310 ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The ...
2016/0151309 PROLONGED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)PHENOL
A pharmaceutical formulation for prolonged release of the active ingredient 3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically acceptable...
2016/0151308 Cycloalkyl-Diamines For Neurodegenerative Disorders
The invention is directed to the use of a compound of formula I as defined herein, a pharmaceutically acceptable salt thereof; or a pharmaceutical composition...
2016/0151307 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2016/0151306 THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID ROE EXTRACT COMPOSITION AND ASSOCIATED METHOD
A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans includes a therapeutic amount of a phospholipid rich egg roe...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.